QT
KPTI icon

Quantbot Technologies’s Karyopharm Therapeutics KPTI Stock Holding History

Quantbot Technologies’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,447
Closed -$29.1K – 1796
2023
Q3 		$29.1K Sell
1,447
-2,179
-60% -$48.9K ﹤0.01% 1318
2023
Q2 		$97.4K Buy
3,626
+413
+13% +$17.8K 0.01% 1185
2023
Q1 		$187K Buy
+3,213
New +$159K 0.01% 923
2022
Q3 		– Sell
-804
Closed -$54K – 1844
2022
Q2 		$54K Sell
804
-2,749
-77% -$252K 0.01% 1291
2022
Q1 		$392K Buy
3,553
+3,146
+773% +$392K 0.03% 671
2021
Q4 		$39K Buy
407
+386
+1,838% +$38.5K ﹤0.01% 1092
2021
Q3 		$1K Buy
+21
New +$2.18K ﹤0.01% 1454
2020
Q4 		– Sell
-136
Closed -$29K – 1497
2020
Q3 		$29K Buy
+136
New +$33.3K ﹤0.01% 957
2020
Q1 		– Sell
-753
Closed -$216K – 1149
2019
Q4 		$216K Buy
+753
New +$163K 0.02% 638
2018
Q4 		– Sell
-282
Closed -$72K – 1218
2018
Q3 		$72K Buy
+282
New +$78K 0.01% 966
2015
Q4 		– Sell
-18
Closed -$2K – 1233
2015
Q3 		$2K Buy
+18
New +$4.81K ﹤0.01% 1139
2014
Q3 		– Sell
-73
Closed -$51K – 1267
2014
Q2 		$51K Buy
+73
New +$34K 0.01% 932

Other funds holding KPTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Quantbot Technologies's KPTI Position: Q4 2023 in Review

Quantbot Technologies sold out of Karyopharm Therapeutics (KPTI) in Q4 2023, closing a stake of 1,447 shares — an estimated $29.1K sold.

Quantbot Technologies first reported a position in KPTI in Q2 2014 and held it in 12 quarters. The position peaked at $392K in Q1 2022. 117 funds tracked by Wall St. Rank hold KPTI as of Q4 2023.

  • Quantbot Technologies reported no remaining Karyopharm Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Quantbot Technologies sold 1,447 Karyopharm Therapeutics shares in Q4 2023, an estimated $29.1K.
  • Quantbot Technologies first reported a position in Karyopharm Therapeutics in Q2 2014 and held it in 12 quarters.
  • Quantbot Technologies's Karyopharm Therapeutics position peaked at $392K in Q1 2022.
  • 117 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2023.

Based on Quantbot Technologies's 13F filing for Q4 2023, filed 14 Feb 2024.